Catalyst by DataFinch vs Pear Therapeutics (reSET) — HIPAA Compliant Software Comparison

Compare Catalyst by DataFinch and Pear Therapeutics (reSET) side-by-side. See how these HIPAA compliant software solutions stack up in features, categories, and compliance.

Need help choosing the right HIPAA software?

Tell us about your practice and we'll recommend the best tools for you.

Tagline

ABA data collection and analysis, now Ensora Data Collection

Prescription digital therapeutic for substance use disorder

Description

Catalyst, built by DataFinch Technologies, is a mobile-first ABA data collection platform for behavior technicians and BCBAs, with discrete trial and skill acquisition data collection, automated graphing, session notes, and a parent portal. DataFinch is now part of Ensora Health (formerly Therapy Brands) and Catalyst is sold today as Ensora Data Collection within the Ensora ABA product line. Ensora's own product page states the platform is HIPAA compliant, lists multi-factor authentication among its features, offers a free 21-day trial with no credit card required, and publishes pricing at $27 per client per month.

reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.

Tags
—
—
Listing Tier
Free
Free

Request Information

Frequently Asked Questions

Which is better, Catalyst by DataFinch or Pear Therapeutics (reSET)?
Both Catalyst by DataFinch and Pear Therapeutics (reSET) are HIPAA compliant software solutions. The best choice depends on your specific needs, practice size, and workflow requirements. Compare their features side-by-side above to find the right fit.
Is Catalyst by DataFinch HIPAA compliant?
Catalyst by DataFinch is listed in the HIPAA Compliant Software directory. Catalyst, built by DataFinch Technologies, is a mobile-first ABA data collection platform for behavior technicians and BCBAs, with discrete trial and skill acquisition data collection, automated graphing, session notes, and a parent portal. DataFinch is now part of Ensora Health (formerly Therapy Brands) and Catalyst is sold today as Ensora Data Collection within the Ensora ABA product line. Ensora's own product page states the platform is HIPAA compliant, lists multi-factor authentication among its features, offers a free 21-day trial with no credit card required, and publishes pricing at $27 per client per month.
Is Pear Therapeutics (reSET) HIPAA compliant?
Pear Therapeutics (reSET) is listed in the HIPAA Compliant Software directory. reSET is a prescription digital therapeutic that delivers a 12-week course of cognitive behavioral therapy with contingency management through a smartphone app, as an adjunct to outpatient treatment for substance use disorder in adults. It was developed by Pear Therapeutics and in 2017 became the first prescription digital therapeutic authorized by the FDA, through the De Novo pathway. Pear Therapeutics filed for Chapter 11 bankruptcy in April 2023 and its assets were sold at auction, but reSET itself is still sold and supported today: PursueCare relaunched it as RESET in October 2024, and XRHealth acquired PursueCare, including RESET and RESET-O, in November 2026.

Related HIPAA Software

Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  
Favicon

 

  
  

Need help choosing the right HIPAA software?

Tell us about your practice and we'll recommend the best tools for you.